RVT-101

Is This the Next Home-Run Biotech Stock?
Motley Fool
Wed, 06/28/17 - 10:42 pm
biotech
Axovant Sciences
intepirdine
RVT-101
Alzheimer’s Drug Pipeline Analysis: Have We Hit Peak Amyloid?
Xconomy
Wed, 06/21/17 - 09:46 am
Alzheimer's disease
anti-amyloid
solanezumab
Eli Lilly
Biogen
aducanumab
RVT-101
Company Run By 30-Year-Old Former Hedge Fund Manager Starts Study To Get Its Alzheimer's Drug Approved
Forbes
Tue, 10/6/15 - 08:12 am
Axovant Sciences
Alzheimer's disease
RVT-101
Doctors Are Optimistic About Axovant's Experimental Alzheimer's Drug
Forbes
Wed, 07/22/15 - 09:43 pm
physicians
Axovant
Alzheimer's disease
RVT-101
GSK